Table of Content

1.Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Viral Therapy, others)
5.2.2. By Service Type (Target Identification and Validation, Lead Screening and Characterization, Cell-based Assays)
5.2.3. By Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map

6. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type
6.2.2. By Service Type
6.2.3. By Cancer Type
6.2.4. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Type
6.3.1.2.2. By Service Type
6.3.1.2.3. By Cancer Type
6.3.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Type
6.3.2.2.2. By Service Type
6.3.2.2.3. By Cancer Type
6.3.3. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Type
6.3.3.2.2. By Service Type
6.3.3.2.3. By Cancer Type
6.3.4. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Drug Type
6.3.4.2.2. By Service Type
6.3.4.2.3. By Cancer Type
6.3.5. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Drug Type
6.3.5.2.2. By Service Type
6.3.5.2.3. By Cancer Type

7. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Service Type
7.2.3. By Cancer Type
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Service Type
7.3.1.2.3. By Cancer Type
7.3.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Service Type
7.3.2.2.3. By Cancer Type
7.3.3. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Service Type
7.3.3.2.3. By Cancer Type
7.3.4. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Service Type
7.3.4.2.3. By Cancer Type
7.3.5. United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Service Type
7.3.5.2.3. By Cancer Type

8. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Service Type
8.2.3. By Cancer Type
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Service Type
8.3.1.2.3. By Cancer Type
8.3.2. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Service Type
8.3.2.2.3. By Cancer Type
8.3.3. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Service Type
8.3.3.2.3. By Cancer Type

9. South America Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Service Type
9.2.3. By Cancer Type
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Service Type
9.3.1.2.3. By Cancer Type
9.3.2. Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Service Type
9.3.2.2.3. By Cancer Type
9.3.3. Colombia Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Service Type
9.3.3.2.3. By Cancer Type
10. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Service Type
10.2.3. By Cancer Type
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Service Type
10.3.1.2.3. By Cancer Type
10.3.2. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Service Type
10.3.2.2.3. By Cancer Type
10.3.3. UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Service Type
10.3.3.2.3. By Cancer Type

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: SWOT Analysis

14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape
16.1. Covance, Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (In case of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2. Horizon Discovery Group PLC
16.3. Crown Bioscience, Inc.
16.4. Promega Corporation
16.5. HD Biosciences Co., Ltd.
16.6. BPS Bioscience, Inc.
16.7. Genscript Biotech Corporation
16.8. DiscoverX Corporation
16.9. Celentyx Ltd.
16.10. ImmunXperts SA

17. Strategic Recommendations

18. About Us & Disclaimer